- Home
- DKNG vs QGEN Comparison
DKNG vs QGEN Comparison
Compare DKNG & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DKNG | QGEN |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 10.2B |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | DKNG | QGEN |
|---|---|---|
| Price | $23.07 | $34.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 31 | 8 |
| Target Price | $38.10 | ★ $45.76 |
| AVG Volume (30 Days) | ★ 10.2M | 1.8M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 7.17% |
| EPS Growth | ★ 99.05 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,054,525,000.00 | N/A |
| Revenue This Year | $15.47 | $8.18 |
| Revenue Next Year | $13.09 | $5.71 |
| P/E Ratio | ★ N/A | $24.01 |
| Revenue Growth | ★ 26.99 | N/A |
| 52 Week Low | $20.46 | $33.17 |
| 52 Week High | $48.78 | $57.82 |
Technical Indicators
Market Signals| Indicator | DKNG | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 48.46 | 25.71 |
| Support Level | $21.21 | N/A |
| Resistance Level | $24.17 | $49.16 |
| Average True Range (ATR) | 0.93 | 0.95 |
| MACD | 0.11 | -0.57 |
| Stochastic Oscillator | 52.29 | 11.90 |
Price Performance
Historical ComparisonAbout DKNG DraftKings Inc.
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number-two or -three revenue share position across states where it competes. DraftKings is now live with online or retail sports betting in 28 states and i-gaming in 5 states, with both products available to around 40% of Canada's population. In 2024, sports revenue was 61% of total sales, i-gaming 32%, and fantasy and lottery 7%. The company plans to launch a predictive event platform in late 2025 and also operates a non-fungible token commission-based marketplace and develops and licenses online gaming products.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).